+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Biodegradable Type Embolic Microspheres Market by Product Type, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6080370
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Biodegradable embolic microspheres are at the forefront of innovation in interventional medicine, unlocking safer and more adaptable options for precise vessel occlusion and targeted therapy. This dynamic market is shaped by rapid advancement in materials science, regional regulatory shifts, and evolving clinical needs, presenting significant opportunities and emerging challenges for industry leaders.

Market Snapshot: Biodegradable Embolic Microspheres

The global biodegradable embolic microspheres market continues to expand, propelled by rising demand for minimally invasive therapeutic options and robust clinical validation of resorbable agents. Senior decision-makers encounter a landscape marked by evolving reimbursement models and increased adoption in oncology and vascular interventions. Strong interest is observed in both established healthcare settings and emerging markets where regulatory environments are experiencing convergence. Growth is additionally supported by a greater focus on patient-centric outcomes, sustainable clinical benefits, and investment in localized supply chain strategies.

Scope & Segmentation of the Market

  • Product Types: Drug-eluting microspheres, with strong positioning for Doxorubicin and Irinotecan formulations; Non drug-eluting microspheres remain relevant in select interventions.
  • Applications: Procedures for arteriovenous malformations, robust usage in liver cancer (covering both metastatic lesions and primary tumors), with emerging activity in prostate cancer embolization and uterine fibroid treatments for fertility preservation.
  • End Users: Hospitals equipped for complex interventional procedures, ambulatory surgical centers catering to high-volume lower-risk cases, and specialty clinics with a focus on interventional oncology and women’s health.
  • Regions Covered: Americas (notably United States with strong centers in California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; plus Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (including key markets such as United Kingdom, Germany, France, Russia, and high-growth areas in Africa and Middle East), and Asia-Pacific (highlighting China, India, Japan, Australia, South Korea, and rapidly developing Southeast Asian economies).
  • Key Companies: Major device manufacturers such as Boston Scientific Corporation, Terumo Corporation, Merit Medical Systems, Inc., Cook Medical LLC, Medtronic plc, AngioDynamics, Inc., Guerbet S.A., MicroVention, Inc., BioSphere Medical, Inc., and Biocompatibles UK Ltd.
  • Technologies: Innovations in drug delivery platforms enabling controlled chemotherapy release; biodegradable polymers facilitating predictable hydrolytic degradation; and collaborative R&D driving new product profiles.

Key Takeaways for Senior Leaders

  • Biodegradable microspheres are redefining minimally invasive embolization by permitting predictable vessel clearing and reducing risks associated with permanent agents.
  • Polymer engineering breakthroughs allow these agents to maintain therapeutic integrity and then resorb without generating permanent foreign body reactions, supporting safer and more flexible clinical regimens.
  • Growth is especially vigorous in liver-related interventions, but nuanced segmentation—such as doxorubicin versus irinotecan usage—continues to inform procurement and clinical protocol decisions at major centers.
  • Ambulatory surgical centers and specialty clinics are gaining ground in procedural volumes, reflecting a broader trend toward decentralized models and cost-effective interventional care.
  • Market leaders achieve competitive advantage by aligning local manufacturing, strategic partnerships, and adaptive distribution strategies to the specific needs of each region.

Tariff Impact on Supply Chains

The implementation of new US tariffs in 2025 has introduced substantial pressures across the biodegradable embolic microspheres supply chain. Higher import duties on polymer precursors and active drug ingredients have led to increased production costs, prompting both pricing recalibrations and contractual renegotiations throughout distribution networks. While larger manufacturers typically leverage scale to absorb some of these impacts, smaller players face delayed market entry or a reorientation of supply partnerships. This environment has initiated a trend toward regional manufacturing and integrated supply models to reduce future exposure to trade policy volatility.

Methodology & Data Sources

Research methodology incorporated direct interviews with interventional radiologists, oncology specialists, and key procurement decision-makers. Data was collected through regulatory filings and a meticulous review of published literature, supported by an in-depth synthesis of industry reports, patent documentation, and clinical trial registries. Both qualitative practitioner insights and quantitative segmentation metrics underpin the analytical rigor of this report.

Why This Report Matters

  • Empowers strategic planning by contextualizing shifts in biodegradable embolic microsphere demand, technology trends, and nuanced application areas across major global markets.
  • Delivers actionable competitive intelligence for product development, procurement, and partnership decisions by providing a comprehensive assessment of manufacturers, technology platforms, and regional regulatory environments.
  • Facilitates risk mitigation through focused analysis of supply chain pressures—including tariff effects—and evolving procurement and clinical adoption trends.

Conclusion

Biodegradable embolic microspheres are setting a new standard for safety, efficacy, and adaptability in interventional therapies. Senior leaders who prioritize data-driven investment and regionalized production strategies will be best positioned to capture future market opportunities.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biodegradable Type Embolic Microspheres Market, by Product Type
8.1. Introduction
8.2. Drug Eluting
8.2.1. Doxorubicin
8.2.2. Irinotecan
8.3. Non Drug Eluting
9. Biodegradable Type Embolic Microspheres Market, by Application
9.1. Introduction
9.2. Arteriovenous Malformations
9.3. Liver Cancer
9.3.1. Metastatic Lesions
9.3.2. Primary Tumors
9.4. Prostate Cancer
9.5. Uterine Fibroids
10. Biodegradable Type Embolic Microspheres Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Americas Biodegradable Type Embolic Microspheres Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Biodegradable Type Embolic Microspheres Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Biodegradable Type Embolic Microspheres Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Boston Scientific Corporation
14.3.2. Terumo Corporation
14.3.3. Merit Medical Systems, Inc.
14.3.4. Cook Medical LLC
14.3.5. Medtronic plc
14.3.6. AngioDynamics, Inc.
14.3.7. Guerbet S.A.
14.3.8. MicroVention, Inc.
14.3.9. BioSphere Medical, Inc.
14.3.10. Biocompatibles UK Ltd
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET MULTI-CURRENCY
FIGURE 2. BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET MULTI-LANGUAGE
FIGURE 3. BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DOXORUBICIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY IRINOTECAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY NON DRUG ELUTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY METASTATIC LESIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRIMARY TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 36. CANADA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 37. CANADA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 38. CANADA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. CANADA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 40. CANADA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. MEXICO BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. MEXICO BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 43. MEXICO BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. MEXICO BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 45. MEXICO BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. UNITED KINGDOM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. UNITED KINGDOM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 64. UNITED KINGDOM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED KINGDOM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 66. UNITED KINGDOM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. GERMANY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. GERMANY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 69. GERMANY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. GERMANY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 71. GERMANY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. FRANCE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. FRANCE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 74. FRANCE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. FRANCE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 76. FRANCE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. RUSSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. RUSSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. ITALY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. ITALY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 84. ITALY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. ITALY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 86. ITALY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. SPAIN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. SPAIN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 89. SPAIN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. SPAIN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 91. SPAIN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. UNITED ARAB EMIRATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. SAUDI ARABIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. SAUDI ARABIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 99. SAUDI ARABIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. SAUDI ARABIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 101. SAUDI ARABIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. SOUTH AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. SOUTH AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 104. SOUTH AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. SOUTH AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 106. SOUTH AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. DENMARK BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. DENMARK BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 109. DENMARK BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. DENMARK BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 111. DENMARK BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. NETHERLANDS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. NETHERLANDS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 114. NETHERLANDS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. QATAR BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. QATAR BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 119. QATAR BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. QATAR BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 121. QATAR BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. FINLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. FINLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 124. FINLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. FINLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 126. FINLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. SWEDEN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. NIGERIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. NIGERIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. EGYPT BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. EGYPT BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 139. EGYPT BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. EGYPT BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 141. EGYPT BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. TURKEY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. TURKEY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 144. TURKEY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. TURKEY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 146. TURKEY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. ISRAEL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. ISRAEL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 149. ISRAEL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. ISRAEL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. NORWAY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. NORWAY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 154. NORWAY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. NORWAY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 156. NORWAY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. POLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. POLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 159. POLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. POLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 161. POLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. SWITZERLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. SWITZERLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 164. SWITZERLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SWITZERLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 166. SWITZERLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 173. CHINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. CHINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 175. CHINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. CHINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 177. CHINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. INDIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. INDIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 180. INDIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. INDIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 182. INDIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. JAPAN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. JAPAN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 185. JAPAN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. JAPAN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 187. JAPAN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. SOUTH KOREA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. THAILAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. THAILAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 205. THAILAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. THAILAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 207. THAILAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. PHILIPPINES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. SINGAPORE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. SINGAPORE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. VIETNAM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. TAIWAN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SHARE, BY KEY PLAYER, 2024
TABLE 234. BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biodegradable Type Embolic Microspheres market report include:
  • Boston Scientific Corporation
  • Terumo Corporation
  • Merit Medical Systems, Inc.
  • Cook Medical LLC
  • Medtronic plc
  • AngioDynamics, Inc.
  • Guerbet S.A.
  • MicroVention, Inc.
  • BioSphere Medical, Inc.
  • Biocompatibles UK Ltd